Therapeutic effects of simultaneous intraluminal irradiation and intraluminal hyperthermia on oesophageal carcinoma

British Journal of Radiology

Volumn 74, Issue 884, 2001, Pages 709-714

  Fuwa, N ^a   Nomoto, Y ^b   Shouji, K ^b   Kodaira, T ^a   Kamata, M ^a   Ito, Y ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IRIDIUM;

ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ESOPHAGUS CARCINOMA; ESOPHAGUS FISTULA; ESOPHAGUS MUCOSA; HUMAN; HYPERTHERMIC THERAPY; IRRADIATION; MALE; MEDICAL INSTRUMENTATION; RADIATION APPLICATOR; RADIATION RESPONSE; RADIOFREQUENCY RADIATION;

EID: 0034870793     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.74.884.740709     Document Type: Article

References (27)

1. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine
2. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer
3. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma
4. High dose rate brachytherapy for superficial cancer of the esophagus
5. External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus
6. Hyperthermochemoradiotherapy and esophageal carcinoma
7. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus - A prospective randomized trial
8. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial
9. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma
10. Recent advances in preoperative hyperthermochemoradiotherapy for patients with esophageal cancer
11. Thermal enhancement of the effectiveness of gamma radiation for induction of reproductive death in cultured mammalian cells
12. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo
13. Biological basis for rational design of clinical treatment with combined hyperthermia and radiation
14. Report of a study using phantom materials, and clinical experience with simultaneous radio-hyperthermotherapy
15. Preliminary survivorship report on combined intraoperative radiation and hyperthermia treatments for unresectable pancreatic adenocarcinoma
16. Clinical system for simultaneous external superficial microwave hyperthermia and cobalt-60 radiation
17. Simultaneous superficial hyperthermia and external radiotherapy: Report of thermal dosimetry and tolerance to treatment
18. Simultaneous intraluminal irradiation and hyperthermia treatment for esophageal carcinoma
19. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group
20. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology
21. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme
22. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomized, multicentre trial
23. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus
24. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
25. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group
26. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus